Life sciences regulatory Partner Xisca Borrás, will be speaking on the third and final day of the EU Pharmaceutical Law Forum conference alongside fellow expert Arianna Greco, Senior Vice President, Head of Global Commercial Legal, Alnylam Pharmaceuticals.
Session details – 25 May at 14:10:
DUAL DIALOGUE: Strategic & Statutory Priority of Environmental, Social, and Governance (ESG)
Topics to be discussed include:
- Approach for ESGs to be meaningfully integrated into your business in the Life Science
- The role of General Counsel and legal departments in this evolving area
- Updates on Swiss reporting requirements on ESGs and the EU Corporate Sustainability
Reporting Directive (CSRD)
- ESGs as part of a wider suite of transparency and trust activities
For more information and to register, see the EU Pharmaceutical Law Forum website.